Advantech EKI-1242EIMS up to 1.06.01 Modbus Transaction Management Interface cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 2.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Advantech EKI-1242EIMS up to 1.06.01. It has been classified as problematic. This issue affects some unknown processing of the component Modbus Transaction Management Interface. The manipulation leads to cross site scripting. This vulnerability is listed as CVE-2026-73169. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability, which was classified as problematic, has been found in Advantech EKI-1242EIMS up to 1.06.01. This issue affects an unknown code block of the component Modbus Transaction Management Interface. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Nozomi Networks Labs identified a CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in the Modbus transaction management interface of Advantech EKI-1242EIMS in firmware version V1.06.01 that allows a remote authenticated attacker to store malicious script content that executes in the browser of any administrator who later opens an affected management page.
The advisory is shared at nozominetworks.com. The identification of this vulnerability is CVE-2026-73169 since 08/11/2026. The exploitation is known to be easy. The attack may be initiated remotely. Additional levels of successful authentication are necessary for exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.advantech.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 2.4VulDB Meta Temp Score: 2.4
VulDB Base Score: 2.4
VulDB Temp Score: 2.4
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
08/11/2026 CVE reserved09/16/2026 Advisory disclosed
09/16/2026 VulDB entry created
09/16/2026 VulDB entry last update
Sources
Vendor: advantech.comAdvisory: nozominetworks.com
Status: Not defined
CVE: CVE-2026-73169 (🔒)
GCVE (CVE): GCVE-0-2026-73169
GCVE (VulDB): GCVE-100-405893
Entry
Created: 09/16/2026 15:37Changes: 09/16/2026 15:37 (64)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.